Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Irene Rivero-Calle, Jose Gómez-Rial, Louis Bont, Bradford D. Gessner, Melvin Kohn, Ron Dagan, Daniel C. Payne, Laia Bruni, Andrew J. Pollard, Adolfo García-Sastre, Denise L. Faustman, Albert Osterhaus, Robb Butler, Francisco Giménez Sánchez, Francisco Álvarez, Myrsini Kaforou, Xabier Bello & Federico Martinón-Torres. (2021) TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines. Human Vaccines & Immunotherapeutics 17:3, pages 759-772.
Read now
Read now
Jamie Findlow, Charles Nuttens & Paula Kriz. (2019) Introduction of a second MenB vaccine into Europe – needs and opportunities for public health. Expert Review of Vaccines 18:3, pages 225-239.
Read now
Read now
John L. Perez, Judith Absalon, Johannes Beeslaar, Paul Balmer, Kathrin U. Jansen, Thomas R. Jones, Shannon Harris, Laura J. York, Qin Jiang, David Radley, Annaliesa S. Anderson, Graham Crowther & Joseph J. Eiden. (2018) From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Expert Review of Vaccines 17:6, pages 461-477.
Read now
Read now
Andrew Vyse, Gillian Ellsbury & Harish Madhava. (2018) Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Review of Vaccines 17:3, pages 229-237.
Read now
Read now
Anne Abio, Keith R. Neal & Charles R. Beck. (2013) An epidemiological review of changes in meningococcal biology during the last 100 years. Pathogens and Global Health 107:7, pages 373-380.
Read now
Read now
Timo Vesikari, Aino Forstén, Dominique Boutriau, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2012) Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers. Human Vaccines & Immunotherapeutics 8:12, pages 1892-1903.
Read now
Read now
Timo Vesikari, Aino Forstén, Dominique Boutriau, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2012) A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years. Human Vaccines & Immunotherapeutics 8:12, pages 1882-1891.
Read now
Read now
Articles from other publishers (21)
Carlo Tascini, Raffaella Iantomasi, Francesco Sbrana, Ciro Carrieri, Daniela D’Angela, Silvia Cocchio, Barbara Polistena, Federico Spandonaro, Eva Agostina Montuori & Vincenzo Baldo. (2023) MAGLIO study: epideMiological Analysis on invasive meninGococcaL disease in Italy: fOcus on hospitalization from 2015 to 2019. Internal and Emergency Medicine.
Crossref
Crossref
Stefan Scholz, Magdalena Schwarz, Ekkehard Beck, Kinga Meszaros, Melanie Schneider, Bernhard Ultsch & Wolfgang Greiner. (2021) Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease. Infectious Diseases and Therapy 11:1, pages 367-387.
Crossref
Crossref
Yunyi Zhang, Xuan Deng, Yan Jiang, Junyan Zhang, Li Zhan, Lingling Mei, Hangjing Lu, Pingping Yao & Hanqing He. (2022) The Epidemiology of Meningococcal Disease and Carriage, Genotypic Characteristics and Antibiotic Resistance of Neisseria meningitidis Isolates in Zhejiang Province, China, 2011–2021. Frontiers in Microbiology 12.
Crossref
Crossref
Charles Nuttens, Jamie Findlow, Paul Balmer, David L Swerdlow & Myint Tin Tin Htar. (2022) Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017. Eurosurveillance 27:3.
Crossref
Crossref
A. A. Vilnits, N. V. Skripchenko, E. Yu. Gorelik, A. V. Astapova, K. V. Markova & E. S. Egorova. (2021) Bacterial purulent meningitis in children: is there a light at the end of the tunnel?. CHILDREN INFECTIONS 20:4, pages 28-34.
Crossref
Crossref
Vasilica Ungureanu. (2020) Invasive meningococcal disease – its importance in human pathology and its prevention. Medic.ro 2:134, pages 38.
Crossref
Crossref
Anastasia Flountzi, Theano Georgakopoulou, Sooria Balasegaram, Konstantinos Kesanopoulos, Athanasia Xirogianni, Anastasia Papandreou & Georgina Tzanakaki. (2019) Epidemiology of invasive meningococcal disease in Greece, 2006–2016. European Journal of Clinical Microbiology & Infectious Diseases 38:12, pages 2197-2203.
Crossref
Crossref
Al-Mamoon Badahdah, Harunor Rashid, Ameneh Khatami & Robert Booy. (2018) Meningococcal disease burden and transmission in crowded settings and mass gatherings other than Hajj/Umrah: A systematic review. Vaccine 36:31, pages 4593-4602.
Crossref
Crossref
Tatjana Baldovin, Roberta Lazzari, Silvia Cocchio, Patrizia Furlan, Chiara Bertoncello, Mario Saia, Francesca Russo & Vincenzo Baldo. (2017) Invasive meningococcal disease in the Veneto region of Italy: a capture-recapture analysis for assessing the effectiveness of an integrated surveillance system. BMJ Open 7:4, pages e012478.
Crossref
Crossref
Robert Whittaker, Joana Gomes Dias, Miriam Ramliden, Csaba Ködmön, Assimoula Economopoulou, Netta Beer & Lucia Pastore Celentano. (2017) The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014. Vaccine 35:16, pages 2034-2041.
Crossref
Crossref
Zuzana Jandova, Martin Musilek, Zuzana Vackova, Jana Kozakova & Pavla Krizova. (2016) Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015. PLOS ONE 11:12, pages e0167762.
Crossref
Crossref
Ernest Kuchar, Katarzyna Miśkiewicz & Monika Karlikowska. (2015) A review of guidance on immunization in persons with defective or deficient splenic function. British Journal of Haematology 171:5, pages 683-694.
Crossref
Crossref
Shruti Sridhar, Brian Greenwood, Christopher Head, Stanley A Plotkin, Marco A Sáfadi, Samir Saha, Muhamed-Kheir Taha, Oyewale Tomori & Bradford D Gessner. (2015) Global incidence of serogroup B invasive meningococcal disease: a systematic review. The Lancet Infectious Diseases 15:11, pages 1334-1346.
Crossref
Crossref
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinón-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel & J.A. Vázquez. (2014) Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes. Anales de Pediatría 80:4, pages 259.e1-259.e23.
Crossref
Crossref
Johannes Elias. (2014) Loosening the grip of meningococcal disease in Africa. The Lancet 383:9911, pages 6-8.
Crossref
Crossref
Anna Skoczyńska, Izabela Waśko, Alicja Kuch, Marcin Kadłubowski, Agnieszka Gołębiewska, Małgorzata Foryś, Marlena Markowska, Patrycja Ronkiewicz, Katarzyna Wasiak, Aleksandra Kozińska, Bożena Matynia & Waleria Hryniewicz. (2013) A Decade of Invasive Meningococcal Disease Surveillance in Poland. PLoS ONE 8:8, pages e71943.
Crossref
Crossref
Jamie D. Croxtall & Sohita Dhillon. (2012) Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™). Drugs 72:18, pages 2407-2430.
Crossref
Crossref
Anna Skoczyńska, Alicja Kuch, Izabela Waśko, Agnieszka Gołębiewska, Patrycja Ronkiewicz, Marlena Markowska, Katarzyna Wasiak & Waleria Hryniewicz. (2012) Inwazyjna choroba meningokokowa u chorych poniżej 20. roku życia w Polsce w latach 2009–2011. Pediatria Polska 87:5, pages 438-443.
Crossref
Crossref
. (2012) Neuer Meningokokken-Impfstoff. Pädiatrie & Pädologie 47:4, pages 30-42.
Crossref
Crossref
Paul B Keiser & Christopher J Gill. (2012) Defining efficacy in meningococcal vaccine trials. Clinical Investigation 2:6, pages 589-601.
Crossref
Crossref
Theodore F. Tsai. (2012) Meningococcal Disease and Quadrivalent MenACWY-CRM Vaccine (Menveo®). Korean Journal of Pediatric Infectious Diseases 19:3, pages 89.
Crossref
Crossref